Inderjit Singh Mann

Title: Inderjit Singh Mann: Innovator in Respiratory Disease Treatment

Introduction

Inderjit Singh Mann is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of respiratory disease treatment through his innovative research and development. With a total of four patents to his name, Mann continues to push the boundaries of medical science.

Latest Patents

Mann's latest patents include groundbreaking compounds aimed at treating respiratory diseases. One of his notable inventions is the phenethanolamine derivatives, specifically the compounds (1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)ethanol and (5R)-3-(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one. These compounds are claimed to be effective in treating respiratory diseases and serve as intermediates for developing further therapeutic agents.

Career Highlights

Inderjit Singh Mann is currently associated with Glaxo Group Limited, where he applies his expertise in pharmaceutical research. His work focuses on developing innovative solutions for respiratory ailments, contributing to the advancement of medical treatments.

Collaborations

Mann has collaborated with esteemed colleagues such as Philip Charles Box and Diane Mary Coe. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Inderjit Singh Mann is a prominent figure in the field of respiratory disease treatment, with a strong portfolio of patents and collaborations. His innovative work continues to impact the medical community positively.